NDRG2 suppresses the expression of transporters and catalytic enzymes, which provide bioenergy and biomaterials for cancer cell proliferation and tumor progression, thereby playing an important role in inhibiting glycolysis and glutaminolysis and restraining tumor cell metabolism [21, 97]. The gene discussed is NDRG2; the disease is neoplasm.